Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Serbia Health Wire.
Swiss Medica Advances Global Access to Stem Cell Therapy for Neurological and Chronic Conditions
EIN Presswire
·
April 29, 2025
Discover how a leading stem cell therapy clinic is making regenerative care more accessible for patients with chronic and neurological disorders. BELGRADE, SERBIA, April 29, 2025 /EINPresswire.com/ -- Swiss Medica, a leading stem cell clinic...
Terra Balcanica Intersects Gold Mineralization Over 72 m and Starts Drill Program At Brezani Target in Bosnia
GlobeNewswire, Inc.
·
August 18, 2025
Vancouver, British Columbia, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Terra Balcanica Resources Corp. (“Terra” or the “Company”) (CSE:TERA; FRA: UB1) is pleased to announce an expansion of the surface gold skarn system at Brezani and the start of the...
Medera Showcased Positive Interim Data From First-in-Human Gene Therapy Trial for HFpEF in Late-Breaking Presentation at Heart Failure 2025 Congress
GlobeNewswire, Inc.
·
May 19, 2025
Results from MUSIC-HFpEF Phase 1/2a clinical trial show favorable safety profile and early clinical benefits with SRD-002 gene therapy BOSTON, May 19, 2025 (GLOBE NEWSWIRE) -- Medera Inc. (“Medera”), a clinical-stage biopharmaceutical company...
Lattice Biologics, Ltd. - 607852 - 08/27/2020
U.S. Food and Drug Administration
·
March 19, 2025
Reference #: CBER 20-06 Product: Biologics Recipient: Recipient Title Chief Executive Officer Lattice Biologics, Ltd. 512 E Madison Avenue Suite 101 Belgrade, MT 59714 United States News@latticebiologics.com Issuing Office: Office of Compliance...
Log-hub Welcomes Richard Groenenboom to Its Board of Directors, Strengthening Industry Expertise in Global Supply Chains
EIN Presswire
·
May 16, 2025
Log-hub appoints Richard Groenenboom to its Board of Directors, bringing 30+ years of Pharma and Supply Chain leadership to strengthen industry alignment. SCHINDELLEGI, SWITZERLAND, May 16, 2025 /EINPresswire.com/ -- Log-hub, the Swiss-based...
SONATA-HCM Study Design Presented at Heart Failure 2025, the Annual Congress of the Heart Failure Association of the European Society of Cardiology
GlobeNewswire, Inc.
·
May 19, 2025
Lexicon is evaluating the safety and efficacy of sotagliflozin in patients with both obstructive and non-obstructive hypertrophic cardiomyopathy (HCM) Pivotal Phase 3 clinical trial is actively enrolling patients in 20 countries, with all sites...
Windtree Therapeutics Announces Istaroxime Presentation at European Society of Cardiology Heart Failure Conference
GlobeNewswire, Inc.
·
May 19, 2025
WARRINGTON, Pa., May 19, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on becoming a revenue generating company and advancing early and late-stage innovative...
Dundee Precious Metals Announces Satisfaction of Bosnian Competition Council Condition for Acquisition of Adriatic Metals
GlobeNewswire, Inc.
·
August 6, 2025
TORONTO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Dundee Precious Metals Inc. (TSX: DPM) (“DPM”) is pleased to report that the condition to the proposed acquisition by DPM of Adriatic Metals plc (“Adriatic”), previously announced on June 13, 2025 (the...
Double Dogs Dispensary Expands Regulated Cannabis Access in Four Corners, Montana
EIN Presswire
·
July 4, 2025
With in-store shopping, pickup, and licensed brands like Cookies, Double Dogs serves Bozeman’s growing adult-use market. BOZEMAN, MT, UNITED STATES, July 3, 2025 /EINPresswire.com/ -- Double Dogs Weed Dispensary continues to serve adult-use...
Acoramidis Reduced Incidence of Atrial Fibrillation Events in Patients with ATTR-CM
GlobeNewswire, Inc.
·
May 20, 2025
- In a post-hoc analysis of ATTRibute-CM, acoramidis reduced the annual frequency of CVH due to AF/AFL by 43% compared to placebo and reduced the incidence of new-onset AF/AFL by 17% in the subgroup with no prior history of AF compared to placebo...
Karen Green McGowan, Founder of IntellectAbility, Passes Away Leaving Behind Legacy of Advocacy and Education
EIN Presswire
·
April 9, 2025
IntellectAbility continues Karen McGowan’s legacy of improving the health and well-being of people with intellectual and developmental disabilities. CLEARWATER, FL, UNITED STATES, April 9, 2025 /EINPresswire.com/ -- Karen Green McGowan, Founder...
Enlight Renewable Energy Reports Second Quarter 2025 Financial Results
GlobeNewswire, Inc.
·
August 6, 2025
All of the amounts disclosed in this press release are in U.S. dollars unless otherwise noted TEL AVIV, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Enlight Renewable Energy (NASDAQ: ENLT, TASE: ENLT) today reported financial results for the second quarter...
Tectonic Therapeutic to Present Phase 1b Data for TX45 at European Society of Cardiology Heart Failure 2025
GlobeNewswire, Inc.
·
April 15, 2025
WATERTOWN, Mass., April 15, 2025 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic”), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the...
Final Statistical Review and Evaluation - Novoeight
U.S. Food and Drug Administration
·
January 30, 2025
DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Food and Drug Administration Statistical Review and Evaluation BLA (FINAL REVIEW) BLA Supplement Number: STN 125466 Product Name: turoctocog alfa Indication(s): Control and prevention...
Cytokinetics Announces Four Upcoming Presentations at the European Society Of Cardiology Heart Failure 2025 Congress
GlobeNewswire, Inc.
·
May 8, 2025
SOUTH SAN FRANCISCO, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced three Late Breaking Science presentations and one ePoster presentation at Heart Failure 2025, an International Congress of the...
Intellia Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Company Progress
GlobeNewswire, Inc.
·
May 8, 2025
On track to complete enrollment of the global Phase 3 HAELO study in hereditary angioedema (HAE) in the third quarter of 2025 Dosed first patient in the global Phase 3 MAGNITUDE-2 study evaluating nexiguran ziclumeran (nex-z) in patients with...
Tectonic Therapeutic Announces First Quarter 2025 Financial Results and Recent Business Highlights
GlobeNewswire, Inc.
·
May 8, 2025
Interim analysis from the TX45 Phase 1b Part A trial demonstrated meaningful improvements in both left ventricular function and pulmonary hemodynamics in patients with Group 2 Pulmonary Hypertension in Heart Failure with Preserved Ejection...
Dundee Precious Metals Announces Filing of Management Information Circular for Acquisition of Adriatic Metals & Name Change
GlobeNewswire, Inc.
·
July 23, 2025
(Unless otherwise noted, all dollar amounts in this release are expressed in U.S dollars.) TORONTO, July 23, 2025 (GLOBE NEWSWIRE) -- Dundee Precious Metals Inc. (TSX: DPM) (“DPM”) is pleased to announce that it has filed its management...
Josh Hudson: Empowering Men to Reignite Their Marriages and Rediscover Their Purpose
EIN Presswire
·
February 7, 2025
SERBIA, February 7, 2025 /EINPresswire.com/ -- Josh Hudson, a licensed therapist, transformative coach, and mentor, is making waves by helping men rebuild their marriages and reclaim the drive to lead on their own terms. Through his proven...
Former Kuehne + Nagel VP Jürgen Rahtz Joins Log-hub as Managing Director for U.S.
EIN Presswire
·
July 22, 2025
Log-hub expands in the U.S. and appoints ex Kuehne + Nagel VP Jürgen Rahtz as Managing Director to support companies with advanced supply chain optimization. HOUSTON, TX, UNITED STATES, July 22, 2025 /EINPresswire.com/ -- Following its recent...